Synopsis Highlights The global Medical Soft Capsules market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. The major global manufacturers of Medical Sof.....
SynopsisThe global Fenticonazole market was valued at US$ 50 million in 2023 and is anticipated to reach US$ 64 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030. Fenticonazole is an antifungal medication that is primarily used for .....
SynopsisThe global Recombinant Fluorescent Proteins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Recombinant Fluorescent Proteins .....
SynopsisCeftriaxone sodium is a cephalosporin antibiotic. The global Ceftriaxone Sodium market was valued at US$ 264.2 million in 2023 and is anticipated to reach US$ 217.6 million by 2030, witnessing a CAGR of -2.7% during the forecast period 2024-2030.
SynopsisHandheld DNA Sequencer refer to a very small DNA sequencer. Due to its very small size, the traditional method of first amplification and then sequencing cannot be used. The third-generation single-molecule speed measurement technology is usually used. Current.....
SynopsisThe global Sternum Saws market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sternum Saws in various end use industries. The expanding demands from the Or.....
Synopsis HemodynamicMonitoringDeviceis thedevices measuretheblood pressureinsidetheveins, heart, and arteries. Italso measures blood flow and how much oxygen is in theblood. The global Hemodynamic Monitoring Systems market size is expected to rea.....
SynopsisThe global CAD-CAM Dental Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of CAD-CAM Dental Systems in various end use industries. The expanding.....
SynopsisRofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available b.....
SynopsisThe global IPL Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for IPL Device is estimated to increase from $ million in 2.....
